TABLE 2.
Susceptibility rates of 30 blaKPC-possessing E. coli isolates according to the 2009 and 2010 CLSI breakpoints
Breakpoint yr | % susceptiblea |
|||||||
---|---|---|---|---|---|---|---|---|
Broth microdilution method |
Etest method |
|||||||
IPM | MER | DOR | ETP | IPM | MER | DOR | ETP | |
2009 | 77 | 77 | 17b | 43 | 47 | 80 | 17b | 47 |
2010 | 3 | 40 | 50 | 0 | 3 | 43 | 23 | 0 |
IPM, imipenem; MER, meropenem; DOR, doripenem; ETP, ertapenem.
Values calculated based on the 2009 FDA-recommended breakpoint for doripenem.